Zoetis Inc (ZTS.N)


ZTS.N on New York Stock Exchange

31.18USD
1:30am IST
Price Change (% chg)

$0.22 (+0.71%)
Prev Close
$30.96
Open
$31.39
Day's High
$31.39
Day's Low
$30.95
Volume
2,993,755
Avg. Vol
531,026
52-wk High
$35.40
52-wk Low
$30.42

ZTS.N

Chart for ZTS.N

About

Zoetis Inc, is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The primary livestock species are cattle (both beef and dairy), swine, poultry, sheep and fish, and the primary companion animal species are dogs,... (more)

Overall

Beta: --
Market Cap (Mil.): $15,480.00
Shares Outstanding (Mil.): 500.00
Dividend: 0.06
Yield (%): 0.84

Financials

  ZTS.N Industry Sector
P/E (TTM): 33.29 31.05 31.28
EPS (TTM): 0.93 -- --
ROI: 9.35 19.56 18.90
ROE: 20.03 20.32 19.80
Search Stocks

Latest News about ZTS.N

Pfizer to spin off Zoetis stake to shareholders

- Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7 percent discount.

22 May 2013

UPDATE 2-Pfizer to spin off Zoetis stake to shareholders

May 22 - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7 percent discount.

22 May 2013

BRIEF-Pfizer up in premarket after plans to unwind remaining majority stake in Zoetis

NEW YORK, May 22 - Pfizer Inc : * Up 2.2 percent to $29.40 in premarket after plans to unwind remaining majority stake in Zoetis

22 May 2013

UPDATE 2-Strong pet product sales help Zoetis top estimates

April 30 - Zoetis Inc, formerly the animal health subsidiary of U.S. pharmaceuticals giant Pfizer Inc , posted a stronger-than-expected quarterly profit, driven by growth in sales of pet products in the United States.

30 Apr 2013

Zoetis profit beats Street on strong pet product sales

April 30 - Zoetis Inc, formerly the animal health subsidiary of U.S. pharmaceuticals giant Pfizer Inc , posted a better-than-expected quarterly profit, driven by strong growth in sales of pet products in the United States.

30 Apr 2013
» More ZTS.N News

Earnings vs. Estimates

Search Stocks